MKI67 and leukemia: However, we also found 70% of normal SCH CD34+ cells to be Ki-67+, also with no difference in mTOR phosphorylation between the Ki-67 ̄ and Ki-67+ subsets, indicating that the Ki-67- subset with active mTOR is not a leukaemia-specific phenotype.